Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 6/20 | 0.66 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.66 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.66 |
| ▸ | MME | P08473 | 2/20 | 0.60 |
| ▸ | LTA4H | P09960 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8574421 | 1.00 | OPRD1 (0.66) | OPRD1OPRM1OPRK1MMELTA4H | |
| SCHEMBL30053179 | 0.92 | OPRD1 (0.68) | OPRD1OPRM1OPRK1MMELTA4H | |
| SCHEMBL29892587 | 0.92 | OPRD1 (0.68) | OPRD1OPRM1OPRK1MME | |
| SCHEMBL31461882 | 0.89 | OPRD1 (0.65) | OPRD1OPRM1OPRK1LTA4H | |
| SCHEMBL29626871 | 0.88 | OPRD1 (0.70) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29355873 | 0.88 | OPRD1 (0.73) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30153107 | 0.88 | OPRD1 (0.63) | OPRD1OPRM1OPRK1LTA4H | |
| SCHEMBL29992506 | 0.87 | OPRD1 (0.65) | OPRD1OPRM1OPRK1LTA4H | |
| Enkephalin SCHEMBL16189980 | 0.86 | OPRD1 (0.75) | OPRD1OPRM1OPRK1 | |
| Enkephalin SCHEMBL631958 | 0.86 | OPRD1 (0.75) | OPRD1OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5817758-A | FOR PEPTIDES | TERRAPIN TECHNOLOGIES, INC. (US) | 1998-10-06 | — | — | US | disclosed |
| WO-1996040735-A1 | p-NITROBENZYL SIDE-CHAIN PROTECTION FOR SOLID-PHASE SYNTHESIS | TERRAPIN TECHNOLOGIES, INC. (US) | 1996-12-19 | — | — | WO | disclosed |